Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants.
On 31 January 2022, the Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application.
A transition period applies to clinical trial submission under the Regulation.
Table of Contents
3. How to report a serious breach
4. Clarification on reporting requirements
5. Reporting serious breaches – Points to consider
6. Responsibilities of parties involved in the notification of a serious breach
7. General considerations for serious breaches
8. Possible actions taken by the EU/EEA Member States concerned (MSC)
Appendix I – Examples of serious breaches
Appendix II – Points to consider for sponsors in relation to the assessment of a breach
Appendix III a – Template form for reporting serious breaches
Appendix III b – Information to be submitted with a notification of a serious breach
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Kommande kliniska prövningar
-
National Cancer Institute (NCI)RekryteringSteg IIA lungcancer AJCC v8 | Steg IIB lungcancer AJCC v8 | Steg IIIA lungcancer AJCC v8 | Steg IIIB lungcancer AJCC v8 | Steg IB Lung icke-småcelligt karcinom AJCC v7 | Steg II, icke-småcellig lungcancer AJCC v7 | Steg IIIA Icke-småcellig lungcancer AJCC v7Förenta staterna, Guam, Puerto Rico
-
Centre Hospitalier Universitaire de la RéunionRekryteringPrimär hemostassjukdom hos hjärtkirurgiska patienterÅterförening
-
The University of Hong KongHealth and Medical Research FundRekryteringKronisk leversjukdomHong Kong
-
Abramson Cancer Center at Penn MedicineRekrytering
-
Zhujiang HospitalRekrytering
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS)Har inte rekryterat ännu
-
Avelo AGUniversity Hospital, Basel, SwitzerlandHar inte rekryterat ännuLunginflammation | Nedre luftvägsinfektion (LRTI)
-
Daré Bioscience, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...Har inte rekryterat ännu
-
OVO LASIK + LensSengiRekrytering
-
University of California, Los AngelesRekryteringIrritabel tarmsyndrom (IBS)Förenta staterna
-
Abbott Diabetes CareRekryteringDiabetes mellitusFörenta staterna
-
Assiut UniversityHar inte rekryterat ännuPatienter med akut leukemi